BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+30.72%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
AUM
$3.11B
AUM Growth
+$3.11B
Cap. Flow
-$232M
Cap. Flow %
-7.45%
Top 10 Hldgs %
51.56%
Holding
91
New
16
Increased
7
Reduced
4
Closed
14
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$388M 12.47% 1,765,560
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$288M 9.25% 1,114,188
SWTX
3
DELISTED
SpringWorks Therapeutics
SWTX
$151M 4.84% 2,075,905
ITOS icon
4
iTeos Therapeutics
ITOS
$147M 4.72% 4,345,016
PMVP icon
5
PMV Pharmaceuticals
PMVP
$74.2M
$140M 4.48% 2,268,236
RVMD icon
6
Revolution Medicines
RVMD
$7.1B
$131M 4.21% 3,309,264
ODT
7
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$108M 3.46% 5,607,086 +400,000 +8% +$7.68M
SAGE
8
DELISTED
Sage Therapeutics
SAGE
$94.6M 3.04% 1,094,000
RCKT icon
9
Rocket Pharmaceuticals
RCKT
$354M
$80.4M 2.58% 1,466,051
SPRY icon
10
ARS Pharmaceuticals
SPRY
$1.15B
$77.6M 2.5% +1,675,377 New +$77.6M
SGEN
11
DELISTED
Seagen Inc. Common Stock
SGEN
$70.1M 2.25% 400,000
BDTX icon
12
Black Diamond Therapeutics
BDTX
$157M
$64.6M 2.08% 2,014,858
LABD icon
13
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$68.5M
$56.9M 1.83% 2,250,000 +2,000,000 +800% +$50.5M
RCUS icon
14
Arcus Biosciences
RCUS
$1.13B
$54.1M 1.74% 2,084,883
RLAY icon
15
Relay Therapeutics
RLAY
$619M
$53.8M 1.73% 1,294,132 +42,173 +3% +$1.75M
FOLD icon
16
Amicus Therapeutics
FOLD
$2.34B
$53.7M 1.73% 2,325,000
SNDX icon
17
Syndax Pharmaceuticals
SNDX
$1.41B
$50.9M 1.64% 2,287,782
ARGX icon
18
argenx
ARGX
$43.6B
$50.3M 1.62% 170,926
PASG icon
19
Passage Bio
PASG
$22.7M
$49.3M 1.58% 1,928,315
CYTK icon
20
Cytokinetics
CYTK
$4.23B
$43.6M 1.4% +2,100,000 New +$43.6M
KNTE
21
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$42.4M 1.36% +1,064,665 New +$42.4M
ALGS icon
22
Aligos Therapeutics
ALGS
$73.3M
$42.2M 1.36% +1,526,048 New +$42.2M
NRIX icon
23
Nurix Therapeutics
NRIX
$714M
$40.3M 1.29% 1,224,892 -129,500 -10% -$4.26M
BCEL
24
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$35.6M 1.14% 2,202,333
KURA icon
25
Kura Oncology
KURA
$686M
$34.3M 1.1% 1,050,289